Lexston Life Sciences Corp. (LEXTF)
USD 0.13
(83.92%)
USD 0.13
(83.92%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -867.71 Thousand CAD | 21.74% |
| 2023 | -867.71 Thousand CAD | 52.21% |
| 2022 | -2.32 Million CAD | -164.83% |
| 2021 | -876.13 Thousand CAD | -13414.27% |
| 2020 | -6483.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -112.41 Thousand CAD | -33.64% |
| 2024 Q4 | -246.47 Thousand CAD | 33.86% |
| 2024 Q2 | -138.17 Thousand CAD | -22.91% |
| 2024 Q3 | -372.67 Thousand CAD | -169.71% |
| 2023 Q4 | -84.12 Thousand CAD | 72.42% |
| 2023 FY | -1.1 Million CAD | 52.21% |
| 2023 Q3 | -304.97 Thousand CAD | 29.15% |
| 2023 Q2 | -430.42 Thousand CAD | -48.82% |
| 2023 Q1 | -289.21 Thousand CAD | 57.46% |
| 2022 FY | -2.32 Million CAD | -164.83% |
| 2022 Q2 | -655.93 Thousand CAD | -25.91% |
| 2022 Q1 | -520.96 Thousand CAD | 0.0% |
| 2022 Q3 | -655.93 Thousand CAD | 0.0% |
| 2022 Q4 | -679.86 Thousand CAD | -3.65% |
| 2021 FY | -876.13 Thousand CAD | -13414.27% |
| 2021 Q3 | -594.35 Thousand CAD | -698.22% |
| 2021 Q2 | -74.46 Thousand CAD | 0.0% |
| 2020 FY | -6483.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 52.97 Million USD | 101.638% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 87.574% |
| CSL Limited | 2.64 Billion USD | 100.033% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 101.332% |
| Regen BioPharma, Inc. | 1.02 Million USD | 184.778% |
| BioStem Technologies, Inc. | -8.48 Million USD | 89.771% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 77.279% |
| Qrons Inc. | -789.34 Thousand USD | -9.928% |
| Nascent Biotech, Inc. | -2.08 Million USD | 58.437% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 98.614% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 89.021% |
| Skye Bioscience, Inc. | -37.64 Million USD | 97.695% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -108.846% |
| Rebus Holdings, Inc. | -1.02 Million USD | 14.93% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 94.533% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | 35.024% |
| Genscript Biotech Corporation | -95.47 Million USD | 99.091% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -37.208% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 98.842% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 86.805% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -217.376% |
| SQZ Biotechnologies Company | -79.46 Million USD | 98.908% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 70.0% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 52.337% |
| Mesoblast Limited | -87.95 Million USD | 99.013% |
| Marizyme, Inc. | -65.34 Million USD | 98.672% |
| Genus plc | 7.9 Million USD | 110.984% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 92.033% |
| Pharming Group N.V. | -10.54 Million USD | 91.774% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 60.01% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 76.613% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 90.189% |
| ContraFect Corporation | -65.15 Million USD | 98.668% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 82.241% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | 49.769% |
| IMV Inc. | -36.48 Million USD | 97.622% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 89.234% |
| MultiCell Technologies, Inc. | -380.07 USD | -228203.47% |
| ONE Bio Corp. | 8.67 Million USD | 110.001% |
| Accustem Sciences Inc. | -3.74 Million USD | 76.839% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 98.321% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | 31.522% |
| Q BioMed Inc. | -2.05 Million USD | 57.716% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 76.756% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 63.555% |
| Biomind Labs Inc. | -1.21 Million USD | 28.543% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 98.547% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 72.025% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 55.485% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -5694.024% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 85.084% |
| GB Sciences, Inc. | -1.36 Million USD | 36.276% |
| Alpha Cognition Inc. | -13.77 Million USD | 93.7% |
| HST Global, Inc. | -146.21 Thousand USD | -493.47% |
| Wesana Health Holdings Inc. | -1.75 Million USD | 50.551% |
| Halberd Corporation | -79.67 Thousand USD | -989.052% |
| Enzolytics Inc. | -2.17 Million USD | 60.139% |
| Agentix Corp. | -1.37 Million USD | 36.857% |
| Resverlogix Corp. | -3.61 Million USD | 75.964% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 72.64% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 99.706% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 985.421% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 112.531% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 78.16% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 71.326% |
| AVAX Technologies, Inc. | -6.41 Million USD | 86.471% |
| Zenith Capital Corp. | -10.59 Million USD | 91.811% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -3633.384% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 79.071% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -1335.646% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 56.725% |
| Kadimastem Ltd | -3.3 Million USD | 73.764% |
| Helix BioMedix, Inc. | -1.05 Million USD | 17.835% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -96.596% |
| LadRx Corporation | 400.44 Thousand USD | 316.688% |
| Cell Source, Inc. | -5.32 Million USD | 83.693% |
| Regen BioPharma, Inc. | 1.02 Million USD | 184.778% |
| NovAccess Global Inc. | -4.76 Million USD | 81.806% |
| Affymax, Inc. | -14.42 Million USD | 93.984% |
| Itoco Inc. | -1.86 Million USD | 53.573% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 80.468% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | 48.01% |
| Mobile Lads Corp. | -2.26 Million USD | 61.661% |
| CytoDyn Inc. | -49.84 Million USD | 98.259% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -997.912% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -280.364% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | 7.84% |
| SYBLEU INC | -180.3 Thousand USD | -381.25% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | 46.196% |
| International Stem Cell Corporation | -131 Thousand USD | -562.376% |
| Bioxytran, Inc. | -4.28 Million USD | 79.726% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -1498.823% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 65.706% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 98.195% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 58.954% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -11.119% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 72.61% |
| Neutra Corp. | -233.46 Thousand USD | -271.667% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 95.724% |
| PureTech Health plc | -65.69 Million USD | 98.679% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 95.92% |
| IXICO plc | -1.17 Million USD | 26.34% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 91.259% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 98.481% |
| CSL Limited | 2.64 Billion USD | 100.033% |
| Cellectis S.A. | -103.17 Million USD | 99.159% |